Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
92.01
-2.43 (-2.57%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Edwards Lifesciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 53,035 | 49,471 | 43,663 | 46,246 | 46,128 | 80,883 | |
Market Cap Growth | 9.24% | 13.30% | -5.58% | 0.25% | -42.97% | 42.25% |
Enterprise Value | 49,457 | 46,323 | 39,982 | 45,142 | 45,077 | 79,772 |
Last Close Price | 92.01 | 85.25 | 74.03 | 76.25 | 74.61 | 129.55 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 53.52 | 46.08 | 10.46 | 32.98 | 30.31 | 53.81 |
Forward PE | 29.32 | 30.93 | 31.19 | 28.41 | 30.35 | 52.98 |
PS Ratio | 8.14 | 8.15 | 8.03 | 9.23 | 10.33 | 15.46 |
PB Ratio | 5.00 | 4.79 | 4.34 | 6.88 | 7.94 | 13.86 |
P/TBV Ratio | 7.28 | 6.65 | 6.20 | 9.06 | 10.59 | 18.62 |
P/FCF Ratio | 36.99 | 37.06 | 150.61 | 71.94 | 47.38 | 57.51 |
P/OCF Ratio | 30.83 | 31.01 | 80.51 | 51.63 | 37.87 | 46.70 |
PEG Ratio | 2.58 | 3.24 | 3.69 | 2.77 | 2.95 | 3.38 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 7.59 | 7.63 | 7.35 | 9.01 | 10.10 | 15.25 |
EV/EBITDA Ratio | 24.77 | 25.81 | 24.62 | 28.05 | 26.81 | 46.34 |
EV/EBIT Ratio | 27.01 | 28.28 | 27.00 | 30.35 | 29.24 | 50.28 |
EV/FCF Ratio | 34.50 | 34.70 | 137.92 | 70.23 | 46.30 | 56.73 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.07 | 0.07 | 0.07 | 0.10 | 0.12 | 0.12 |
Debt / EBITDA Ratio | 0.35 | 0.39 | 0.42 | 0.42 | 0.40 | 0.39 |
Debt / FCF Ratio | 0.49 | 0.53 | 2.42 | 1.07 | 0.71 | 0.49 |
Net Debt / Equity Ratio | -0.33 | -0.34 | -0.33 | -0.14 | -0.09 | -0.13 |
Net Debt / EBITDA Ratio | -1.79 | -1.97 | -2.02 | -0.59 | -0.31 | -0.45 |
Net Debt / FCF Ratio | -2.49 | -2.64 | -11.32 | -1.47 | -0.54 | -0.55 |
Asset Turnover | 0.48 | 0.45 | 0.49 | 0.57 | 0.53 | 0.67 |
Inventory Turnover | 1.27 | 1.21 | 1.12 | 1.10 | 0.90 | 1.63 |
Quick Ratio | 3.45 | 2.83 | 3.13 | 2.06 | 1.87 | 2.07 |
Current Ratio | 4.52 | 3.72 | 4.18 | 3.38 | 3.03 | 3.08 |
Return on Equity (ROE) | 9.18% | 10.35% | 16.64% | 19.48% | 22.74% | 28.88% |
Return on Assets (ROA) | 8.37% | 7.65% | 8.26% | 10.53% | 11.47% | 12.60% |
Return on Invested Capital (ROIC) | 17.39% | 19.98% | 21.26% | 23.92% | 25.98% | 31.39% |
Return on Capital Employed (ROCE) | 14.80% | 13.80% | 12.80% | 18.20% | 21.20% | 21.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.87% | 2.17% | 9.56% | 3.03% | 3.30% | 1.86% |
FCF Yield | 2.70% | 2.70% | 0.66% | 1.39% | 2.11% | 1.74% |
Buyback Yield / Dilution | 1.64% | 2.25% | 1.66% | 2.37% | 1.11% | 0.11% |